Evaluation of Development of Nonalcoholic Fatty Pancreas Disease After Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in Liver Transplant Patients: Computerized Tomography Versus Ultrasound

Basit Öğe Kaydı
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridNuransoy Cengiz, Ayse/0000-0001-9133-8602
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.contributor.authorCengiz, Ayse Nuransoy
dc.contributor.authorBilgic, Yilmaz
dc.contributor.authorKaratoprak, Sinan
dc.contributor.authorGokce, Ayse
dc.contributor.authorEvren, Bahri
dc.contributor.authorAkbulut, Sami
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:10:23Z
dc.date.available2024-08-04T20:10:23Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground/Aims: Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common serious adverse event in liver transplant patients The average incidence has been reported as 1.3%-15.1% in prospective series. In our study, we have prospectively evaluated the prevalence of nonalcoholic fatty pancreatic disease (NAFPD) after PEP via computerized tomography (CT) and determined the ratio of fatty pancreas by ultrasound imaging in liver transplant patients. Materials and Methods: We have retrospectively analyzed 2922 patient files, and 146 patients were indicated for ERCP. PEP was observed in 32 patients. After presenting the significant association between the NAFPD and PEP, we prospectively reached 32 patients included in the study. Ten out of those patients have been performed ultrasound with regard to NAFPD. Results: PEP was defined in 32 patients in whom CT was performed to investigate NAFPD. When the patients were contacted, it was observed that 12% were deceased, 71% were alive, but 15% of them were untraceable. Ultrasound has been performed on 10 of 32 patients to determine NAFPD. There was a significant reduction in post-PEP pancreas/spleen rate compared to pre-PEP pancreas/ spleen rate (P =.001). Both the pre-PEP and post-PEP pancreas-spleen difference dropped significantly (P =.002). Conclusion: Ultrasound imaging could be utilized as a scanning test and an alternative to evaluate and diagnose NAFPD, particularly in risky patients.en_US
dc.identifier.doi10.5152/tjg.2023.22424
dc.identifier.endpage1185en_US
dc.identifier.issn2148-5607
dc.identifier.issue11en_US
dc.identifier.pmid37823315en_US
dc.identifier.scopus2-s2.0-85175660864en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1180en_US
dc.identifier.trdizinid1241343en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2023.22424
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1241343
dc.identifier.urihttps://hdl.handle.net/11616/92752
dc.identifier.volume34en_US
dc.identifier.wosWOS:001127633000010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectUltrasounden_US
dc.subjectliver transplantationen_US
dc.subjectPEPen_US
dc.subjectNAFLDen_US
dc.subjectNAFPDen_US
dc.titleEvaluation of Development of Nonalcoholic Fatty Pancreas Disease After Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in Liver Transplant Patients: Computerized Tomography Versus Ultrasounden_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu